Differential aggregation properties of alpha-synuclein isoforms

Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different α-synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of α-synuclein isoforms...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of aging Vol. 35; no. 8; pp. 1913 - 1919
Main Authors Bungeroth, May, Appenzeller, Silke, Regulin, Annika, Völker, Wolfgang, Lorenzen, Inken, Grötzinger, Joachim, Pendziwiat, Manuela, Kuhlenbäumer, Gregor
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.08.2014
Subjects
Online AccessGet full text
ISSN0197-4580
1558-1497
1558-1497
DOI10.1016/j.neurobiolaging.2014.02.009

Cover

Abstract Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different α-synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of α-synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical α-synuclein isoform of 140 amino acid residues (SNCA140), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms (SNCA140, SNCA126, and SNCA98) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140. Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of α-synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that α-synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo.
AbstractList Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different α-synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of α-synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical α-synuclein isoform of 140 amino acid residues (SNCA140), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms (SNCA140, SNCA126, and SNCA98) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140. Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of α-synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that α-synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo.Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different α-synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of α-synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical α-synuclein isoform of 140 amino acid residues (SNCA140), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms (SNCA140, SNCA126, and SNCA98) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140. Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of α-synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that α-synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo.
Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different α-synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of α-synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical α-synuclein isoform of 140 amino acid residues (SNCA140), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms (SNCA140, SNCA126, and SNCA98) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140. Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of α-synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that α-synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo.
Pathologic aggregation of alpha -synuclein is a central process in the pathogenesis of Parkinson's disease. The alpha -synuclein gene (SNCA) encodes at least 4 different alpha -synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of alpha -synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical alpha -synuclein isoform of 140 amino acid residues (SNCA140), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms (SNCA140, SNCA126, and SNCA98) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140. Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of alpha -synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that alpha -synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo.
Abstract Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene ( SNCA ) encodes at least 4 different α-synuclein isoforms through alternative splicing ( SNCA140 , SNCA126 , SNCA112 , SNCA98 ). Differential expression of α-synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical α-synuclein isoform of 140 amino acid residues ( SNCA140 ), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms ( SNCA140 , SNCA126 , and SNCA98 ) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140 . Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of α-synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that α-synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo.
Author Bungeroth, May
Kuhlenbäumer, Gregor
Appenzeller, Silke
Lorenzen, Inken
Pendziwiat, Manuela
Regulin, Annika
Grötzinger, Joachim
Völker, Wolfgang
Author_xml – sequence: 1
  givenname: May
  surname: Bungeroth
  fullname: Bungeroth, May
  organization: Department of Neurology, University of Kiel, Kiel, Germany
– sequence: 2
  givenname: Silke
  surname: Appenzeller
  fullname: Appenzeller, Silke
  organization: Department of Neurology, University of Kiel, Kiel, Germany
– sequence: 3
  givenname: Annika
  surname: Regulin
  fullname: Regulin, Annika
  organization: Department of Neurology, University of Kiel, Kiel, Germany
– sequence: 4
  givenname: Wolfgang
  surname: Völker
  fullname: Völker, Wolfgang
  organization: Leibniz-Institute for Atherosclerosis Research, University of Münster, Münster, Germany
– sequence: 5
  givenname: Inken
  surname: Lorenzen
  fullname: Lorenzen, Inken
  organization: Institute of Biochemistry, University of Kiel, Kiel, Germany
– sequence: 6
  givenname: Joachim
  surname: Grötzinger
  fullname: Grötzinger, Joachim
  organization: Institute of Biochemistry, University of Kiel, Kiel, Germany
– sequence: 7
  givenname: Manuela
  surname: Pendziwiat
  fullname: Pendziwiat, Manuela
  organization: Department of Neurology, University of Kiel, Kiel, Germany
– sequence: 8
  givenname: Gregor
  surname: Kuhlenbäumer
  fullname: Kuhlenbäumer, Gregor
  email: g.kuhlenbaeumer@neurologie.uni-kiel.de
  organization: Department of Neurology, University of Kiel, Kiel, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24629672$$D View this record in MEDLINE/PubMed
BookMark eNqNkkGL1DAUx4OsuLOrX0F68OCl9SVNmhZE0V1XhQUP6jmk6WvNmEnGpBXm25s6q-CCMKd3-b0fj___XZAzHzwS8oxCRYE2L7aVxyWG3ganJ-unigHlFbAKoHtANlSItqS8k2dkA7STJRctnJOLlLYAILlsHpFzxhvWNZJtyOtrO44Y0c9Wu0JPU8RJzzb4Yh_DHuNsMRVhLLTbf9NlOvjFOLS-sCmMIe7SY_Jw1C7hk7t5Sb7evPty9aG8_fT-49Wb29KIWszlIEde9wzNwCT00nQdykaMg25qo1uoUbY9IA49g0GAYdhT2vGmaVquW8na-pI8P3rzWT8WTLPa2WTQOe0xLElRUfMWOsHFCSjjVOaEWEaf3qFLv8NB7aPd6XhQf_LJwMsjYGJIKeL4F6Gg1jrUVv1bh1rrUMBUriOvv723buz8O945autOldwcJZjz_WkxqmQseoODjWhmNQR7qujVPZFx1luj3Xc8YNqGJfrcoaIq5QX1eX2f9XsoB8ieNY3r_wtOv-MXPPLfFA
CitedBy_id crossref_primary_10_1111_neup_12289
crossref_primary_10_1016_j_mad_2023_111807
crossref_primary_10_20517_and_2024_15
crossref_primary_10_1007_s12035_021_02596_3
crossref_primary_10_1038_s41598_023_45078_3
crossref_primary_10_1002_cne_23901
crossref_primary_10_1007_s10048_015_0449_x
crossref_primary_10_1038_s41583_023_00717_6
crossref_primary_10_3389_fnmol_2019_00189
crossref_primary_10_1016_j_arr_2019_100937
crossref_primary_10_54101_ACEN_2022_4_7
crossref_primary_10_1134_S1819712421040073
crossref_primary_10_1111_jnc_13392
crossref_primary_10_1021_acschemneuro_8b00140
crossref_primary_10_1074_jbc_REV120_011743
crossref_primary_10_1016_j_drugalcdep_2015_05_045
crossref_primary_10_1021_acs_jpcb_2c03676
crossref_primary_10_1016_j_nbd_2023_106337
crossref_primary_10_1002_mgg3_407
crossref_primary_10_1016_j_exger_2018_12_008
crossref_primary_10_3390_molecules27061776
crossref_primary_10_3390_biom11081067
crossref_primary_10_3390_biology12020155
crossref_primary_10_1007_s00702_019_02025_9
crossref_primary_10_1016_j_biochi_2020_10_019
crossref_primary_10_23868_201707012
crossref_primary_10_3390_biom5032073
crossref_primary_10_1186_s40478_014_0176_9
crossref_primary_10_3390_genes9020063
crossref_primary_10_1073_pnas_2313465121
Cites_doi 10.1111/j.1365-2990.2004.00572.x
10.1021/bi027363r
10.1016/S0002-9440(10)64781-5
10.1074/jbc.M107045200
10.1016/S0140-6736(04)17103-1
10.1007/s10048-007-0106-0
10.1111/j.1471-4159.2007.04764.x
10.1523/JNEUROSCI.2617-07.2007
10.1126/science.1090278
10.1016/S0022-2836(02)00735-0
10.1097/01.wnr.0000224773.66904.e7
10.1073/pnas.0400553101
10.1007/s10048-008-0124-6
10.1126/science.276.5321.2045
10.1111/j.1742-4658.2007.05733.x
10.1038/ng.487
10.1007/s00109-003-0464-5
10.1212/01.wnl.0000271080.53272.c7
10.1038/ncb748
10.1038/42166
10.1111/j.1471-4159.2008.05407.x
10.1074/jbc.M411805200
ContentType Journal Article
Copyright 2014 Elsevier Inc.
Elsevier Inc.
Copyright © 2014 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2014 Elsevier Inc.
– notice: Elsevier Inc.
– notice: Copyright © 2014 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
DOI 10.1016/j.neurobiolaging.2014.02.009
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList MEDLINE - Academic

MEDLINE
Neurosciences Abstracts


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1558-1497
EndPage 1919
ExternalDocumentID 24629672
10_1016_j_neurobiolaging_2014_02_009
S0197458014002012
1_s2_0_S0197458014002012
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-~X
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
9JO
AABNK
AADFP
AAEDT
AAEDW
AAGJA
AAGUQ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABFRF
ABGSF
ABIVO
ABJNI
ABLJU
ABMAC
ABMZM
ABOYX
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ACXNI
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEFWE
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRLJ
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDW
HMK
HMO
HMQ
HVGLF
HZ~
IHE
J1W
KOM
LX8
M29
M2V
M41
MO0
MOBAO
MVM
N9A
O-L
O9-
OAUVE
OD~
OKEIE
OO0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SSB
SSH
SSN
SSU
SSY
SSZ
T5K
WUQ
Z5R
ZGI
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
RIG
AADPK
AAIAV
ABLVK
ABYKQ
AFYLN
AJBFU
DOVZS
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ACLOT
~HD
7TK
ID FETCH-LOGICAL-c535t-d7f43b2ecd270b7c99e765fda63ca803e78b0eedb20d50c2eb119466684a87283
IEDL.DBID .~1
ISSN 0197-4580
1558-1497
IngestDate Sun Sep 28 11:32:42 EDT 2025
Sun Sep 28 01:29:29 EDT 2025
Mon Jul 21 06:07:25 EDT 2025
Tue Jul 01 01:28:10 EDT 2025
Thu Apr 24 23:06:09 EDT 2025
Fri Feb 23 02:27:29 EST 2024
Sun Feb 23 10:19:35 EST 2025
Tue Aug 26 19:57:19 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Aggregation
Parkinson
Alpha-synuclein
Isoforms
Language English
License Copyright © 2014 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c535t-d7f43b2ecd270b7c99e765fda63ca803e78b0eedb20d50c2eb119466684a87283
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 24629672
PQID 1524174972
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1534809545
proquest_miscellaneous_1524174972
pubmed_primary_24629672
crossref_primary_10_1016_j_neurobiolaging_2014_02_009
crossref_citationtrail_10_1016_j_neurobiolaging_2014_02_009
elsevier_sciencedirect_doi_10_1016_j_neurobiolaging_2014_02_009
elsevier_clinicalkeyesjournals_1_s2_0_S0197458014002012
elsevier_clinicalkey_doi_10_1016_j_neurobiolaging_2014_02_009
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-08-01
PublicationDateYYYYMMDD 2014-08-01
PublicationDate_xml – month: 08
  year: 2014
  text: 2014-08-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Neurobiology of aging
PublicationTitleAlternate Neurobiol Aging
PublicationYear 2014
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Danzer, Haasen, Karow, Moussaud, Habeck, Giese, Kretzschmar, Hengerer, Kostka (bib7) 2007; 27
Singleton, Farrer, Johnson, Singleton, Hague, Kachergus, Hulihan, Peuralinna, Dutra, Nussbaum, Lincoln, Crawley, Hanson, Maraganore, Adler, Cookson, Muenter, Baptista, Miller, Blancato, Hardy, Gwinn-Hardy (bib17) 2003; 302
Beyer, Lao, Carrato, Mate, Lopez, Ferrer, Ariza (bib5) 2004; 30
Beyer, Humbert, Ferrer, Lao, Carrato, Lopez, Ferrer, Ariza (bib4) 2006; 17
Simon-Sanchez, Schulte, Bras, Sharma, Gibbs, Berg, Paisan-Ruiz, Lichtner, Scholz, Hernandez, Kruger, Federoff, Klein, Goate, Perlmutter, Bonin, Nalls, Illig, Gieger, Houlden, Steffens, Okun, Racette, Cookson, Foote, Fernandez, Traynor, Schreiber, Arepalli, Zonozi, Gwinn, van der Brug, Lopez, Chanock, Schatzkin, Park, Hollenbeck, Gao, Huang, Wood, Lorenz, Deuschl, Chen, Riess, Hardy, Singleton, Gasser (bib16) 2009; 41
Beyer, Domingo-Sabat, Lao, Carrato, Ferrer, Ariza (bib3) 2008; 9
Fujiwara, Hasegawa, Dohmae, Kawashima, Masliah, Goldberg, Shen, Takio, Iwatsubo (bib9) 2002; 4
Lashuel, Petre, Wall, Simon, Nowak, Walz, Lansbury (bib11) 2002; 322
Murray, Giasson, Quinn, Koppaka, Axelsen, Ischiropoulos, Trojanowski, Lee (bib13) 2003; 42
Beyer, Domingo-Sabat, Humbert, Carrato, Ferrer, Ariza (bib2) 2008; 9
Duda, Giasson, Chen, Gur, Hurtig, Stern, Gollomp, Ischiropoulos, Lee, Trojanowski (bib8) 2000; 157
Ulmer, Bax, Cole, Nussbaum (bib21) 2005; 280
Ahn, Kim, Kim, Park, Lee, Min, Kim, Kim, Kim, Kim, Cho, Jeon (bib1) 2008; 70
Chartier-Harlin, Kachergus, Roumier, Mouroux, Douay, Lincoln, Levecque, Larvor, Andrieux, Hulihan, Waucquier, Defebvre, Amouyel, Farrer, Destee (bib6) 2004; 364
Spillantini, Schmidt, Lee, Trojanowski, Jakes, Goedert (bib18) 1997; 388
Lee, Choi, Lee (bib12) 2002; 277
Opazo, Krenz, Heermann, Schulz, Falkenburger (bib14) 2008; 106
Jao, Der-Sarkissian, Chen, Langen (bib10) 2004; 101
Polymeropoulos, Lavedan, Leroy, Ide, Dehejia, Dutra, Pike, Root, Rubenstein, Boyer, Stenroos, Chandrasekharappa, Athanassiadou, Papapetropoulos, Johnson, Lazzarini, Duvoisin, Di Iorio, Golbe, Nussbaum (bib15) 1997; 276
Uversky (bib22) 2007; 103
Stefani, Dobson (bib19) 2003; 81
Tsigelny, Bar-On, Sharikov, Crews, Hashimoto, Miller, Keller, Platoshyn, Yuan, Masliah (bib20) 2007; 274
Opazo (10.1016/j.neurobiolaging.2014.02.009_bib14) 2008; 106
Polymeropoulos (10.1016/j.neurobiolaging.2014.02.009_bib15) 1997; 276
Singleton (10.1016/j.neurobiolaging.2014.02.009_bib17) 2003; 302
Beyer (10.1016/j.neurobiolaging.2014.02.009_bib5) 2004; 30
Murray (10.1016/j.neurobiolaging.2014.02.009_bib13) 2003; 42
Ulmer (10.1016/j.neurobiolaging.2014.02.009_bib21) 2005; 280
Chartier-Harlin (10.1016/j.neurobiolaging.2014.02.009_bib6) 2004; 364
Duda (10.1016/j.neurobiolaging.2014.02.009_bib8) 2000; 157
Lashuel (10.1016/j.neurobiolaging.2014.02.009_bib11) 2002; 322
Simon-Sanchez (10.1016/j.neurobiolaging.2014.02.009_bib16) 2009; 41
Jao (10.1016/j.neurobiolaging.2014.02.009_bib10) 2004; 101
Stefani (10.1016/j.neurobiolaging.2014.02.009_bib19) 2003; 81
Beyer (10.1016/j.neurobiolaging.2014.02.009_bib4) 2006; 17
Fujiwara (10.1016/j.neurobiolaging.2014.02.009_bib9) 2002; 4
Tsigelny (10.1016/j.neurobiolaging.2014.02.009_bib20) 2007; 274
Beyer (10.1016/j.neurobiolaging.2014.02.009_bib2) 2008; 9
Ahn (10.1016/j.neurobiolaging.2014.02.009_bib1) 2008; 70
Lee (10.1016/j.neurobiolaging.2014.02.009_bib12) 2002; 277
Spillantini (10.1016/j.neurobiolaging.2014.02.009_bib18) 1997; 388
Danzer (10.1016/j.neurobiolaging.2014.02.009_bib7) 2007; 27
Beyer (10.1016/j.neurobiolaging.2014.02.009_bib3) 2008; 9
Uversky (10.1016/j.neurobiolaging.2014.02.009_bib22) 2007; 103
References_xml – volume: 70
  start-page: 43
  year: 2008
  end-page: 49
  ident: bib1
  article-title: alpha-Synuclein gene duplication is present in sporadic Parkinson disease
  publication-title: Neurology
– volume: 9
  start-page: 15
  year: 2008
  end-page: 23
  ident: bib3
  article-title: Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases
  publication-title: Neurogenetics
– volume: 103
  start-page: 17
  year: 2007
  end-page: 37
  ident: bib22
  article-title: Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation
  publication-title: J. Neurochem.
– volume: 302
  start-page: 841
  year: 2003
  ident: bib17
  article-title: alpha-Synuclein locus triplication causes Parkinson's disease
  publication-title: Science
– volume: 27
  start-page: 9220
  year: 2007
  end-page: 9232
  ident: bib7
  article-title: Different species of alpha-synuclein oligomers induce calcium influx and seeding
  publication-title: J. Neurosci.
– volume: 322
  start-page: 1089
  year: 2002
  end-page: 1102
  ident: bib11
  article-title: Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
  publication-title: J. Mol. Biol.
– volume: 4
  start-page: 160
  year: 2002
  end-page: 164
  ident: bib9
  article-title: alpha-Synuclein is phosphorylated in synucleinopathy lesions
  publication-title: Nat. Cell Biol.
– volume: 101
  start-page: 8331
  year: 2004
  end-page: 8336
  ident: bib10
  article-title: Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling
  publication-title: Proc. Natl. Acad. Sci. U.S.A
– volume: 41
  start-page: 1308
  year: 2009
  end-page: 1312
  ident: bib16
  article-title: Genome-wide association study reveals genetic risk underlying Parkinson's disease
  publication-title: Nat. Genet.
– volume: 364
  start-page: 1167
  year: 2004
  end-page: 1169
  ident: bib6
  article-title: Alpha-synuclein locus duplication as a cause of familial Parkinson's disease
  publication-title: Lancet
– volume: 277
  start-page: 671
  year: 2002
  end-page: 678
  ident: bib12
  article-title: Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form
  publication-title: J. Biol. Chem.
– volume: 42
  start-page: 8530
  year: 2003
  end-page: 8540
  ident: bib13
  article-title: Role of alpha-synuclein carboxy-terminus on fibril formation in vitro
  publication-title: Biochemistry
– volume: 81
  start-page: 678
  year: 2003
  end-page: 699
  ident: bib19
  article-title: Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution
  publication-title: J. Mol. Med.
– volume: 280
  start-page: 9595
  year: 2005
  end-page: 9603
  ident: bib21
  article-title: Structure and dynamics of micelle-bound human alpha-synuclein
  publication-title: J. Biol. Chem.
– volume: 157
  start-page: 1439
  year: 2000
  end-page: 1445
  ident: bib8
  article-title: Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies
  publication-title: Am. J. Pathol.
– volume: 388
  start-page: 839
  year: 1997
  end-page: 840
  ident: bib18
  article-title: Alpha-synuclein in Lewy bodies
  publication-title: Nature
– volume: 17
  start-page: 1327
  year: 2006
  end-page: 1330
  ident: bib4
  article-title: Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease
  publication-title: Neuroreport
– volume: 106
  start-page: 529
  year: 2008
  end-page: 540
  ident: bib14
  article-title: Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging
  publication-title: J. Neurochem.
– volume: 30
  start-page: 601
  year: 2004
  end-page: 607
  ident: bib5
  article-title: Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies
  publication-title: Neuropathol. Appl. Neurobiol.
– volume: 276
  start-page: 2045
  year: 1997
  end-page: 2047
  ident: bib15
  article-title: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
  publication-title: Science
– volume: 274
  start-page: 1862
  year: 2007
  end-page: 1877
  ident: bib20
  article-title: Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein
  publication-title: FEBS J.
– volume: 9
  start-page: 163
  year: 2008
  end-page: 172
  ident: bib2
  article-title: Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease
  publication-title: Neurogenetics
– volume: 30
  start-page: 601
  year: 2004
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib5
  article-title: Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies
  publication-title: Neuropathol. Appl. Neurobiol.
  doi: 10.1111/j.1365-2990.2004.00572.x
– volume: 42
  start-page: 8530
  year: 2003
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib13
  article-title: Role of alpha-synuclein carboxy-terminus on fibril formation in vitro
  publication-title: Biochemistry
  doi: 10.1021/bi027363r
– volume: 157
  start-page: 1439
  year: 2000
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib8
  article-title: Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)64781-5
– volume: 277
  start-page: 671
  year: 2002
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib12
  article-title: Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M107045200
– volume: 364
  start-page: 1167
  year: 2004
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib6
  article-title: Alpha-synuclein locus duplication as a cause of familial Parkinson's disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)17103-1
– volume: 9
  start-page: 15
  year: 2008
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib3
  article-title: Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases
  publication-title: Neurogenetics
  doi: 10.1007/s10048-007-0106-0
– volume: 103
  start-page: 17
  year: 2007
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib22
  article-title: Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2007.04764.x
– volume: 27
  start-page: 9220
  year: 2007
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib7
  article-title: Different species of alpha-synuclein oligomers induce calcium influx and seeding
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.2617-07.2007
– volume: 302
  start-page: 841
  year: 2003
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib17
  article-title: alpha-Synuclein locus triplication causes Parkinson's disease
  publication-title: Science
  doi: 10.1126/science.1090278
– volume: 322
  start-page: 1089
  year: 2002
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib11
  article-title: Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
  publication-title: J. Mol. Biol.
  doi: 10.1016/S0022-2836(02)00735-0
– volume: 17
  start-page: 1327
  year: 2006
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib4
  article-title: Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease
  publication-title: Neuroreport
  doi: 10.1097/01.wnr.0000224773.66904.e7
– volume: 101
  start-page: 8331
  year: 2004
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib10
  article-title: Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling
  publication-title: Proc. Natl. Acad. Sci. U.S.A
  doi: 10.1073/pnas.0400553101
– volume: 9
  start-page: 163
  year: 2008
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib2
  article-title: Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease
  publication-title: Neurogenetics
  doi: 10.1007/s10048-008-0124-6
– volume: 276
  start-page: 2045
  year: 1997
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib15
  article-title: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
  publication-title: Science
  doi: 10.1126/science.276.5321.2045
– volume: 274
  start-page: 1862
  year: 2007
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib20
  article-title: Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein
  publication-title: FEBS J.
  doi: 10.1111/j.1742-4658.2007.05733.x
– volume: 41
  start-page: 1308
  year: 2009
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib16
  article-title: Genome-wide association study reveals genetic risk underlying Parkinson's disease
  publication-title: Nat. Genet.
  doi: 10.1038/ng.487
– volume: 81
  start-page: 678
  year: 2003
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib19
  article-title: Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution
  publication-title: J. Mol. Med.
  doi: 10.1007/s00109-003-0464-5
– volume: 70
  start-page: 43
  year: 2008
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib1
  article-title: alpha-Synuclein gene duplication is present in sporadic Parkinson disease
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000271080.53272.c7
– volume: 4
  start-page: 160
  year: 2002
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib9
  article-title: alpha-Synuclein is phosphorylated in synucleinopathy lesions
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb748
– volume: 388
  start-page: 839
  year: 1997
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib18
  article-title: Alpha-synuclein in Lewy bodies
  publication-title: Nature
  doi: 10.1038/42166
– volume: 106
  start-page: 529
  year: 2008
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib14
  article-title: Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2008.05407.x
– volume: 280
  start-page: 9595
  year: 2005
  ident: 10.1016/j.neurobiolaging.2014.02.009_bib21
  article-title: Structure and dynamics of micelle-bound human alpha-synuclein
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M411805200
SSID ssj0007476
Score 2.2803779
Snippet Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different...
Abstract Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene ( SNCA ) encodes at least...
Pathologic aggregation of alpha -synuclein is a central process in the pathogenesis of Parkinson's disease. The alpha -synuclein gene (SNCA) encodes at least 4...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1913
SubjectTerms Aggregation
Alpha-synuclein
alpha-Synuclein - chemistry
alpha-Synuclein - metabolism
Amino Acid Sequence
Brain - metabolism
HEK293 Cells
Humans
Internal Medicine
Isoforms
Molecular Sequence Data
Neurology
Parkinson
Parkinson Disease - genetics
Protein Aggregates
Protein Aggregation, Pathological - metabolism
Protein Isoforms - metabolism
Title Differential aggregation properties of alpha-synuclein isoforms
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0197458014002012
https://www.clinicalkey.es/playcontent/1-s2.0-S0197458014002012
https://dx.doi.org/10.1016/j.neurobiolaging.2014.02.009
https://www.ncbi.nlm.nih.gov/pubmed/24629672
https://www.proquest.com/docview/1524174972
https://www.proquest.com/docview/1534809545
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEB9KBfFF1PpxWssKxbd4281-hSLlqC2nYl-00Ldld7NbrtTc0Vwf-uLf7uwmuVK0peJjlgwJs_Px22TmNwDbmPQtk1YW2lpfcBF94aKLheY1jw4PLNqmBudvR3J6zL-ciJM12B96YVJZZR_7u5ieo3W_Mu61OV7MZuPvCE4UF4n9JGGePGmYc5Vs_cOv6zIPhMuya5lO_N6aPoTt6xqvzBmZ2I7yRKBU6MU7Bs_qtjR1GwzN6ejwCTzucSSZdK_6FNZC8ww2Jg2eoX9ekfckV3bmT-YbsPepn4KC3nxO7CkesU_zhpBF-hR_kThVyTyS3HdbtFdN4jieNWTWzhOkbZ_D8eHBj_1p0Q9OKLwoxbKoVeSlY8HXTFGnfFUFJUWsrSy91bQMSjuKydExWgvqGcbrncQzLzW3WiHgeAHrzbwJr4BYBBBC0RhoWfHoZeWicmWQuKTwaBhGsDvoyfieVTwNtzg3Q_nYmbmpZZO0bCgzqOURiJX0omPXuKfcx2FLzNBBijHPYBq4p7z6m3xoewduzY5p8U7zh5GNYG8lecNO_-HZ7wYbMujK6f-MbcL8Ep8pEE4pXil21z0l1wiLuRjBy84AV5pjXLJKKvb6v9_xDTxKV12h4yasLy8uw1sEX0u3lb1rCx5MPn-dHv0GsvUywA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqIgEXBJTHtjyMVHEL6zp-RQhVVaFaoO2FVurNsh27WlSyq2Z76IXfzoyTbFVBURFXJ6NE43l8Tma-IWQTkr7jyqnCOBcKIVMofPKpMKIWycOBxThscD44VJNj8eVEnqyQ3aEXBssq-9jfxfQcrfuVca_N8Xw6HX8DcKKFRPYTxDw4afiOwDEHYNTvfl7VeQBeVl3PNBJ8G3aXbF4VeWXSSKQ7yiOBsNJLdBSe1U156iYcmvPR3kPyoAeSdKd710dkJTaPydpOA4foH5f0Lc2lnfmb-RrZ_tiPQQF3PqPuFM7Yp3lH6By_xZ8jqSqdJZobb4v2skGS42lDp-0MMW37hBzvfTranRT95IQiyFIuilonUXoeQ8018zpUVdRKptqpMjjDyqiNZ5AdPWe1ZIFDwN5ConllhDMaEMdTstrMmvicUAcIQmqWIisrkYKqfNK-jAqWNJwN44i8H_RkQ08rjtMtzuxQP_bdXteyRS1bxi1oeUTkUnre0WvcUu7DsCV2aCGFoGchD9xSXv9JPra9B7d2y7Zwp_3NykZkeyl5zVD_4dlvBhuy4Mv4g8Y1cXYBz5SAp7SoNP_bPaUwgIuFHJFnnQEuNceF4pXSfP2_3_E1uTc5Oti3-58Pv26Q-3ilq3p8QVYX5xfxJSCxhX-VPe0XUvA0SQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+aggregation+properties+of+alpha-synuclein+isoforms&rft.jtitle=Neurobiology+of+aging&rft.au=Bungeroth%2C+May&rft.au=Appenzeller%2C+Silke&rft.au=Regulin%2C+Annika&rft.au=V%C3%B6lker%2C+Wolfgang&rft.date=2014-08-01&rft.eissn=1558-1497&rft.volume=35&rft.issue=8&rft.spage=1913&rft_id=info:doi/10.1016%2Fj.neurobiolaging.2014.02.009&rft_id=info%3Apmid%2F24629672&rft.externalDocID=24629672
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01974580%2FS0197458014X00059%2Fcov150h.gif